Your browser doesn't support javascript.
loading
FDG-PET response and outcome from anti-PD-1 therapy in metastatic melanoma.
Tan, A C; Emmett, L; Lo, S; Liu, V; Kapoor, R; Carlino, M S; Guminski, A D; Long, G V; Menzies, A M.
Afiliación
  • Tan AC; Melanoma Institute Australia and The University of Sydney, Sydney, Australia; Department of Medical Oncology, Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, Australia.
  • Emmett L; Melanoma Institute Australia and The University of Sydney, Sydney, Australia; Department of Nuclear Medicine, St Vincent's Hospital, Sydney, Australia; The University of New South Wales, Sydney, Australia.
  • Lo S; Melanoma Institute Australia and The University of Sydney, Sydney, Australia.
  • Liu V; Department of Nuclear Medicine, St Vincent's Hospital, Sydney, Australia.
  • Kapoor R; Department of Radiology, Royal Prince Alfred Hospital, Sydney, Australia; Mater Hospital, Sydney, Australia.
  • Carlino MS; Melanoma Institute Australia and The University of Sydney, Sydney, Australia; Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, Sydney, Australia.
  • Guminski AD; Melanoma Institute Australia and The University of Sydney, Sydney, Australia; Department of Medical Oncology, Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, Australia; Mater Hospital, Sydney, Australia.
  • Long GV; Melanoma Institute Australia and The University of Sydney, Sydney, Australia; Department of Medical Oncology, Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, Australia; Mater Hospital, Sydney, Australia.
  • Menzies AM; Melanoma Institute Australia and The University of Sydney, Sydney, Australia; Department of Medical Oncology, Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, Australia; Mater Hospital, Sydney, Australia. Electronic address: alexander.menzies@sydney.edu.au.
Ann Oncol ; 29(10): 2115-2120, 2018 10 01.
Article en En | MEDLINE | ID: mdl-30137228
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fluorodesoxiglucosa F18 / Tomografía de Emisión de Positrones / Receptor de Muerte Celular Programada 1 / Ipilimumab / Antineoplásicos Inmunológicos / Melanoma Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fluorodesoxiglucosa F18 / Tomografía de Emisión de Positrones / Receptor de Muerte Celular Programada 1 / Ipilimumab / Antineoplásicos Inmunológicos / Melanoma Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article